Endometriosis Treatment Danger

Drug Commonly Used to Treat Endometriosis Linked to Ovarian Cancer
By Liza Jane Maltin

March 19, 2002 — A drug used to combat endometriosis may increase a woman’s risk of developing ovarian cancer. Researchers have found that women taking danazol are three times more likely to get the disease than if they take an alternate drug.

The team from the University of Pittsburgh Graduate School of Public Health presented their findings March 17 at a gynecologic oncologists meeting in Miami.

Endometriosis is a painful condition in which pieces of the uterine lining — the endometrium — migrate outside the uterus and grow abnormally.

Roberta B. Ness, MD, MPH, associate professor of epidemiology, and colleagues reviewed pooled data from two studies including more than 1,300 women with ovarian cancer and nearly 2,000 similarly aged healthy women. They looked at the relationship between endometriosis, endometriosis treatments, and ovarian cancer.

In all, 195 of the women with cancer and 195 of the healthy women had been treated for endometriosis. Women with endometriosis were one and a half times more likely than those without endometriosis to have ovarian cancer.

The researchers found that women with endometriosis who’d taken danazol were nearly three times more likely than were women who’d taken another drug to have ovarian cancer. This link held even after taking into account various factors known to influence the risk of getting ovarian cancer including having been on the pill, having had a baby, and having a family history of the disease.

“Our previous studies have found that women with endometriosis are already at a 50% increased risk for ovarian cancer, and treating them with danazol appears to further increase their risk. This new result, even though it is preliminary, may factor into the equation when [doctors] and their patients with endometriosis are deciding on the best treatment,” says Ness in a news release.

© 2002 WebMD Inc. All rights reserved.

URLS that lead to different articles on Endometriosis

he following URLS lead to different articles on endometriosis.

Recurrence of Endometriosis Associated with Hormone Replacement Therapy in a Woman Following Hysterectomy:
https://web.archive.org/web/20091008125648/http://www.obgyn.net:80/endo/articles/endo-hrt.htm

Autoimmune Disease More Likely with Endometriosis:

Results of SprayGel(TM) Adhesion Barrier System”

Fighting Scar Tissue in the OR: New Surgical Gel Reduces Risk of Adhesions Forming After Gynecologic Surgery :
http://www.jnj.com/news_finance/457.htm

Endometriosis & Dioxin: a Toxic Link?:

Successful Pregnancies after Endo

World’s First Womb Transplant

FDA Approves Anti-adhesion substance

The information in this article is from the Endometriosis Association Newsletter Vol. 23, No.1, 2002.

The FDA has approved the use of Gynecare Inergel Solution, a gel that is poured into the abdomnial cavity after surgery to separate organs and tissues as they heal, during laparotomies. This gel, which hopefully prevents adhesions, has been in use in Europe since 1998 during both laparotomies and laprascopies.

Genetic Link to Endometriosis – Unique Icelandic Study

28 February 2002

A woman has more than five times the normal risk of developing endometriosis if her sister has the
disease, according to research published today
(Thursday 28 February) in Europe’s leading
reproductive medicine journal, Human Reproduction*.

Moreover, even having a cousin with endometriosis
raises a woman’s risk by over 50%, according to the Icelandic team who carried out the research.

This is the first study to analyse the occurrence of
endometriosis across an entire population, and to
demonstrate an increased likelihood of developing
the disease between relatives outside the nuclear
family. It thus provides evidence of a significant
genetic component to endometriosis, as well as a
unique framework for identifying key genes involved in the development of the disease.

deCODE genetics, whose scientists led the research team, plans to use this information to develop a DNA-based test that can identify women at risk and make non-surgical diagnosis possible. This information will also be used to try to discover new treatments.

Endometriosis is a painful and distressing condition
in which endometrial tissue, which under normal
circumstances is found only in the lining of the
womb, develops outside the uterus and attaches itself to ligaments and organs in the abdominal cavity. This tissue responds to the menstrual cycle as though it were still inside the uterus. The repeated growth and disintegration of endometrial tissue in the abdomen can cause bleeding, pain, inflammation, adhesions and infertility. Between 1 and 5 percent of women are thought to suffer from endometriosis in their reproductive years.

The scientists from deCODE genetics and Iceland’s
National University Hospital, both based in Reykjavik, used deCODE’s unique genealogical database for the study. This computerised database includes the entire present-day Icelandic population of 290,000, as well as nearly 85% of all the Icelanders who have lived to adulthood since the country was settled in the ninth century.

“By using our population-wide genealogical resources and statistical models for measuring kinship, we have for the first time demonstrated the existence of a hereditary component to endometriosis that can be traced beyond first-generation relatives,” said Dr Kari Stefansson, Chief Executive Officer of deCODE and
co-author of the article. “This could not have been
achieved anywhere else in the world. The study is also important as the basis for a genome-wide scan to identify key genes that contribute to the disease. We are advancing in this effort, which we hope will contribute to the development of a DNA-based diagnostic test. Such a test would assist in diagnosing the disease and in identifying women at particular risk of endometriosis, without
the need for invasive procedures.”

Assisted by Professor Reynir Geirsson, chairman of the Department of Obstetrics and Gynecology at the National University Hospital, the researchers compiled a list of all 750 women in Iceland who had a surgical diagnosis of endometriosis between 1981 and 1993. This list was then run against deCODE’s geneaology database to analyse the women’s family connections. Applying several measures of familiality, deCODE’s scientists
demonstrated that the affected women were
significantly more interrelated than matched control
groups, highlighting the involvement of inherited
factors. All data on individuals in this research were anonymized and encrypted by the Icelandic government’s Data Protection Authority.

Although other research has reported an increased risk of endometriosis between first-degree relatives with the disease, this is the first in the world to demonstrate the link with cousins.

“It is extremely difficult in most countries to
discover whether second, third and fourth degree
relatives – and even more distant relatives – have
the disease. This is due in part to the fact that
endometriosis requires invasive surgery for accurate diagnosis, and is thus severely under diagnosed. Furthermore, people often don’t know who their non-immediate relatives are or, if they do, may not feel close enough to speak about medical histories,” said Dr Stefansson. “This has made it exceedingly difficult for researchers elsewhere to look at the disease beyond the nuclear family.”

Commented Professor Geirsson: “We found that among sisters there was a 5.2-fold increase in the risk of being diagnosed with endometriosis. The risk among first cousins was lower, but still significantly higher than in the control groups. Sisters share half of their genomes, but cousins share 12.5% and the difference seen for the latter group may therefore more accurately reflect the genetic liability.”

The research team emphasised that establishing the link between cousins was a crucial achievement. By looking at the population as a whole rather than just immediate family groups, and by counting only one member of each cluster of first degree relatives when calculating the relatedness of those with the disease, they had minimised bias. They had also gained a much
more accurate picture of endometriosis risk in a
society, rather than simply in a nuclear family. From
the inheritance pattern seen in the study it was also
evident that the genetic factors involved in
endometriosis can be inherited through paternal as
well as maternal lines.

One message to emerge from the study is that women who want children but have endometriosis in the family might consider pregnancy earlier rather than later in their reproductive life, as the condition does tend to progress with time. Also, if a woman had many of the symptoms of endometriosis and a relative with the condition, she and her doctor may want to consider her having a laparoscopy to confirm or rule-out the condition.

* Genetic factors contribute to the risk of developing endometriosis. Human Reproduction.
Vol.17. No.3. pp 555-559.

Source: Human Reproduction (Journal of the European Society of Human Reproduction and Embryology)

© Health-News.co.uk, a division of Health Media Group

Arianna and Michael (Arianna) – #5 January 26, 2002

For just over a week now I’ve been suffering from this annoying pain on my left side and lower back that steadily got worse. Not only that but I kept running to the bathroom even if I only drank a thimble full of water. I suspected a kidney infection.

I finally made an appointment with the doctor and I saw her yesterday morning and guess what…I’ve got a kidney infection. I went in, did a urine sample, the receptionist dipped the stick in it and asked if i was expecting my period any day now. I said nope not for another 2 weeks, and she said oh hmm, I said I’m susceptible to high protein levels. The doctor came in, looked at the stick, asked where the pain was, said “Yup you have a kidney infection” She wasn’t happy about me waiting an entire week but she understood why I had done it.
She’s given me a course of Macrobid to take for 7 days. She hopes I won’t have an allergic reaction to this stuff. She also ordered me to drink lots of cranberry juice. I wanted to laugh since that’s what I’d already prescribed for myself. :o)
I guess I’m going to have to not ignore any pain that I do have, especially if I realise it’s not endo pain. Oh well…Live and let Learn as they say.

Danielle’s Story about Endo on the Lung

It was 3 years ago now when i started finding it hard to take a deep breath and swallow. I put it down to the fact i had a bad cough and that i also smoke.

It was a few months later when i first coughed up blood which scared the hell out of me. I then realised that there was definitely something wrong and it wasn’t all down to a cough. I went to see my doctor who told me i had a chest infection and prescribed me antibiotics. he also sent me for a chest x-ray just to be sure. Results of my x-ray came back as clear and so i presumed it was just the chest infection. A month later from the 1st episode i coughed up blood yet again and went back to the doctors who sent my phelgm away to be tested. I still hadn’t realised that this was happening only when i had my period. My phelgm came back clear and by this time i had coughed up blood once more. The doctor then wanted to send the blood i was coughing up away and so i did this waiting a month at a time. this time the results came back with an infection and i was prescribed the correct antibiotics. Yet again the same thing happened, i coughed up blood and this time i noticed i was on my period and that it seemed roughly 4 weeks between each episode. I went back to my doctors again and i explained about it co-inciding with my period and he mentioned to me endometriosis although he stated this was extremely rare. He wanted me to go away and keep a diary for 3 months which i did and sure enough on the 1st day of my period i would cough up blood. My doctor referred me to a chest specialist who carried out a CT scan which showed up nothing. He then performed a broncoscopy which is a camera down my throat into my lungs to see any abnormalities and they found a patch of endo on the tubes from my throat to my lungs. I then had to be referred to a gynaecologist for my treatment. Ihabe now finished my treatment of hormone therapy and i feel worse now than when i was coughing up blood. My throat feels constantly raw and i still find it difficult to breathe deeply and swallow. I seem to pick up colds and coughs really easily and i feel physically run-down. My whole body aches, even brushing my teeth is an effort and i’ve been back to my doctors who are saying i have stress??????? I don’t have a lot of pain occassionally i get cramps in my chest but they are more irritating than painful. The chest specialist did mention to me the possibility of cutting part of my lung away or freezing the affected area but i havent heard from him since.

I hope this helps sorry its so long-winded. There is very little info out there on endometriosis in other parts of the body and i never knew if my symptoms were due to endo or something else. I’m relieved to find that its not all in my head and that the symptoms are real.
By Danielle Parker

More Information on Lupron

Lupron Depot interrupts normal menstruation and the production of estrogen.

The absence of estrogen reduces the growth of endometrial tissue. In some cases, Lupron can shrink the implants and provide significant relief from pain.

This medication creates a pseudo-menopause. Even though most women stop having periods during treatment, occasional spotting can occur. If you continue to have regular menstruation after your second injection, you should notify your physician. You could also experience hot flashes, headaches and vaginal dryness, which are menopausal symptoms.

A reduction in estrogen might also cause a reduction in bone mineral density. Once treatment is stopped, this is partially or completely recovered.
©Abbot Laboratories, Limited LUG/4A01 – April 1998

Information About Lupron

This article contains information on Lupron that I have gotten from the Inserts that came with my first Lupron shot.
From the Patient Information Insert that came with my Lupron shot:

-it is for intramuscular use only

-it comes in 3.75mg (1-Month slow release) and 11.25mg (3-Month slow release)

-it’s limited to women 18 years of age and over

-the proper use of Lupron Depot:
-very important your physician checks your progress at regular check-ups

-you might get a local skin reaction: itching, redness, burning and/or swelling at the injection site; the reactions are usually mild and disappear within a few days; if they persist or worsen, tell your physician

-you might get hot flashes; if they continue and make you feel uncomfortable, tell your physician

-if you develop: severe bone pain, severe hot flashes, heavy sweating, severe pain in the chest or abdomen, abnormal swelling or numbness of limbs, persistent nausea or vomiting, rapid heart beat or nervousness, contact your physician immediately


if you think you might be pregnant, contact your physician immediately

-always remember to:

-check with your physician or pharmacist before taking any other medications, including non-prescription (for colds, nausea)

The above information was from the Patient Information insert distributed by ABBOT LABORATORIES, LIMITED October 1999
From another Information Insert that came with my Lupron shot:
Lupron Depot is also known as leuprolide acetate for depot suspension; this is a synthetic, nonapeptide analog of naturally occurring gonadotropin-releasing hormone (GnRH or LHRH)

-it acts as a potent inhibitor of gonadotropin production when administered properly

-it exerts specific action on the pituitary gonadotrophs and the human reproductive tract

General Warnings from the Insert:
-isolated cases of short-term worsening of signs and symptoms have been reported during initiation of Lupron therapy

General Precautions from the Insert:
-those on Lupron therapy should be assessed on a regular basis by their attending physician

  1. Changes in Bone Density
  2. Changes in Laboratory Values during treatment: Plasma Enzymes, Haematology, Lipids,
  3. The safety of re-treatment as well as treatment beyond 6 months with Lupron has not been established.

Adverse Reactions:
-body odour, flu symptoms, injection site reactions, palpitations, syncope, tachycardia, dry mouth, thirst, appetite changes, anxiety, personality disorder, memory disorder, delusions, insomnia/sleep disorders, androgen-like effects, alopecia, hair disorder, nail disorder, ecchymosis, lymphadenopathy, rhinitis, ophthalmologic disorders, conjunctivitis, taste perversion, dysuria, lactation, menstrual disorders

-mood swings, including depression, have been reported as physiological effect of decreased sex steroids

-the following symptoms have been reported by patients while using this medication, but the relationship of the symptoms to Lupron hasn’t been established

-symptoms consistent with fibromyalgia (joint and muscle pain, headaches, sleep disorders, gastrointestinal distress, and shortness of breath)

The above information was from an insert that was distributed by ABBOT LABORATORIES, LIMITED July 1999

Arianna and Michael (Michael) – #4 January 13th, 2002

Right – Time for another entry – this months difficult period is finally over – seemed to go a bit faster this month…

I think it went faster as I was less involved due to Arianna’s depression with her period this time- it has meant she has been very quiet compared to normal – makes it very hard to know what she is thinking as she becomes very withdrawn – she also snaps a lot – not a big issue for me. However i feel her family bear the brunt of it – especially since my little miss becomes very stubborn in some opinions and hates it when she feels peoeel are intruding on hr space.
Unfortunately I cannot do very much for her at this time – maybe it will improve when she comes over – if not I am sure we can come to some sort of compromise 🙂

She worries about my reaction needlessly really and she tends to worry about coming to england due to all the unknowns we have at the moment – however I believe all will be ok and we will resolve all !!

Thats all for now

Mike

Proudly powered by WordPress | Theme: Baskerville 2 by Anders Noren.

Up ↑